2m 2m 2m 2m 2m 2m 2m
MINERVA NEUROSCI (NERV)
NASDAQ
$3.27+$0.04 (+1.24%)
Price as of Oct 02, 2026 4:17 PM EDT- $154.2MMarket Cap
- 53.38%1-Year Change
- BiotechnologyIndustry
MINERVA NEUROSCI (NERV)
$3.27+$0.04 (+1.24%)
NERV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.23 | ||
Change | -$0.12 (-3.58%) | ||
Open | $3.35 | ||
High | $3.35 | ||
Low | $3.17 | ||
Previous Close | $3.35 | ||
Volume | 89,216 | ||
30-Day Average Volume | 154,939 | ||
1-Week Change | -6.38% | ||
1-Month Change | -27.90% | ||
1-Year Change | 53.38% | ||
3-Year Change | -53.19% | ||
5-Year Change | -74.45% | ||
Fundamentals | |||
Shares Outstanding | 47.7M | ||
Total Assets | $95.1M | ||
Market Cap | $154.2M | ||
Enterprise Value | $129.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | $17.5M | ||
Free Cash Flow | -$13.3M | ||
EBIT | $17.5M | ||
EBITDA | $17.5M | ||
Net Working Capital | $75.8M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | 7 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -1 | ||
P/E | -23 | ||
PEG | -0 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 8 | ||
Last Split Date | 06/21/2022 | ||
Earnings & Revenue